Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 71335-1920

3 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 71335-1920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351920)

Label (Lbl713351920)
Label for Olmesartan Medoxomil 20 mg tablet, film coated, oral use. The label states it is packaged by Bryant Ranch Prepack in Burbank, CA, and compares the product to Benicar 20 mg tablet by ScieGen Pharmaceuticals Inc. The label indicates a quantity of 30 tablets, includes storage instructions to keep at 20-25°C (68-77°F), a warning to keep drugs out of children's reach, and displays the NDC 71335-1920-1 along with a barcode.*
FDA Label Image

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)

Structural Formula For Olmesartan Medoxomil (Olmesartan Medox Tabs Figure 1)
Chemical structure of olmesartan medoxomil, the active ingredient of this prescription drug tablet. The diagram shows the molecular arrangement of atoms and bonds characteristic of olmesartan medoxomil.*
FDA Label Image

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)

Olmesartan Medoxomil Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Olmesartan Medox Tabs Figure 2)
A line graph showing the dose response of olmesartan medoxomil in reducing systolic and diastolic blood pressure (mmHg). The X-axis represents olmesartan medoxomil dose (mg) ranging from 0 to 100, and the Y-axis shows reduction in blood pressure (mmHg) up to 14. Two lines illustrate a higher reduction for systolic BP compared to diastolic BP as dose increases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.